Ureteral Stents Market Introduction and Overview
According to SPER Market Research, the Global Ureteral Stents Market is estimated to reach USD 1151.29 million by 2034 with a CAGR of 7.18%.
The ureteral stents market is growing because of more cases of urological diseases like kidney stones and urinary tract infections, especially among older people. Better technology in stents, including new materials and improved comfort for patients, also helps this growth. Additionally, better healthcare in developing areas and more kidney transplants are important trends. The market is expected to continue expanding due to the rising number of urological diseases linked to lifestyle and infections. Key growth factors include more kidney transplants, an aging population, and advancements in stent design. However, the market has challenges, such as a lack of skilled professionals and possible side effects of stents.
- Allium Medical Solutions Ltd. declared in October 2020 that following a successful trial, their urological stents were granted the CE Mark for a new indication in the treatment of urethral fistula. The business was able to expand its clientele thanks to this approval.
By Material: Polymer ureteral stents lead the market, accounting for the majority of revenue in 2024. This rise is being driven by advances in materials, which have resulted in biocompatible, flexible, and lightweight stents that improve patient comfort. The expanding prevalence of urological problems, such as kidney stones and urinary tract infections, has increased the need for efficient therapies like polymer stents. Metallic ureteral stents are predicted to expand steadily over the projection period due to their longevity and resistance to encrustation. These stents can stay in place for longer periods of time without needing to be replaced as frequently, making them excellent for patients with chronic diseases. The growing number of kidney transplants and urology operations fuels the demand for metallic stents.
By Application: Based on Application, Kidney stones dominate the market, accounting for the majority of revenue in 2024, owing mostly to the increasing prevalence of urolithiasis. Sedentary lifestyles, poor food choices, and rising obesity rates have all contributed to the prevalence of this illness. Furthermore, procedures like ureteroscopy and ureterorenoscopy frequently necessitate the use of ureteral stents to handle stone fragments and avoid obstructions. Advances in minimally invasive surgical procedures have increased demand for effective stenting solutions by improving treatment options and patient outcomes.
By Region: North America leads the global ureteral stents market, holding the largest revenue share in 2024, driven by the high prevalence of urological disorders such as kidney stones and urinary tract infections. The region benefits from a well-established healthcare infrastructure and advanced medical technologies, which enable effective treatment options. Additionally, the growing aging population contributes to a higher incidence of kidney-related diseases, further fueling demand. The presence of key market players, along with ongoing research and development efforts, also supports the market's growth in this region.
Market Competitive Landscape
The Global Ureteral Stents Market is highly consolidated. Some of the market players are Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Merit Medical Systems, Inc., Olympus Corporation, Pnn Medical A/S, and Teleflex Inc.
Scope of the Report:
Report Metric | Details |
Market size available for years | 2021-2034 |
Base year considered | 2024 |
Forecast period | 2025-2034 |
Segments covered | By Material, By Application.
|
Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
Companies Covered | Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Merit Medical Systems, Inc., Olympus Corporation, Pnn Medical A/S, and Teleflex Inc. |
Key Topics Covered in the Report:
- Global Ureteral Stents Market Size (FY’2021-FY’2034)
- Overview of Global Ureteral Stents Market
- Segmentation of Global Ureteral Stents Market By Material (Metallic Ureteral Stents, Polymer Ureteral Stents)
- Segmentation of Global Ureteral Stents Market By Application (Kidney Stones, Kidney Transplantation, Tumors, Urinary Incontinence, Others)
- Statistical Snap of Global Ureteral Stents Market
- Expansion Analysis of Global Ureteral Stents Market
- Problems and Obstacles in Global Ureteral Stents Market
- Competitive Landscape in the Global Ureteral Stents Market
- Details on Current Investment in Global Ureteral Stents Market
- Competitive Analysis of Global Ureteral Stents Market
- Prominent Players in the Global Ureteral Stents Market
- SWOT Analysis of Global Ureteral Stents Market
- Global Ureteral Stents Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Ureteral Stents Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Ureteral Stents Market
7. Global Ureteral Stents Market, By Material (USD Million) 2021-2034
7.1. Metallic Ureteral Stents
7.2. Polymer Ureteral Stents
7.2.1. Silicone Stents
7.2.2. Polyurethane Stents
7.2.3. Hybrid Stents
8. Global Ureteral Stents Market, By Application (USD Million) 2021-2034
8.1. Kidney Stones
8.2. Kidney Transplantation
8.3. Tumors
8.4. Urinary Incontinence
8.5. Others
9. Global Ureteral Stents Market Forecast, (USD Million) 2021-2034
9.1. Global Ureteral Stents Market Size and Market Share
10. Global Ureteral Stents Market, By Region, (USD Million) 2021-2034
10.1. Asia-Pacific
10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe
10.3. Middle East and Africa
10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa
10.4. North America
10.4.1. Canada
10.4.2. Mexico
10.4.3. United States
10.5. Latin America
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America
11. Company Profile
11.1. Allium Medical
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. B.Braun Melsungen AG
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Becton, Dickinson and Company
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Boston Scientific Corporation
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Coloplast
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Cook Medical
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Merit Medical Systems, Inc.
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Olympus Corporation
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Pnn Medical A/S
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Teleflex Inc.
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.